| Overview |
| bsm-63031r-100ul |
| SOX9 Recombinant Antibody |
| WB, FCM, IHC-P, IHC-F, IF(IHC-P), IF(ICC) |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human SOX9 |
| Recombinant |
| IgG |
| 1mg/ml |
| Purified by Protein A. |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 6662 |
| Cytoplasm, Nucleus |
| CMD 1; CMD1; CMPD 1; CMPD1; SOX 9; Sox9; SOX9_HUMAN; SRA 1; SRA1 antibody SRY(sex determining region Y) box 9(campomelic dysplasia autosomal; SRY(sex determining region Y) box 9; SRY(sex determining region Y)-box 9; SRY(sex-determining region Y)-box 9 protein; Transcription factor SOX 9; Transcription factor SOX-9; transcription factor SOX9; campomelic dysplasia autosomal sex reversal. |
| Application Dilution |
| WB |
1:1000-5000 |
| FCM |
FCM1:50-100 |
| IHC-P |
IHC-P1:200-1000 |
| IHC-F |
IHC-F1:200-1000 |
| IF(IHC-P) |
IFIHC-P1:200-1000 |
| IF(ICC) |
IFICC1:50-200 |